» Articles » PMID: 39202769

Revisiting the COVID-19 Pandemic: Mortality and Predictors of Death in Adult Patients in the Intensive Care Unit

Overview
Journal Life (Basel)
Specialty Biology
Date 2024 Aug 29
PMID 39202769
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 has generated a global impact due to its contagiousness and high lethality rates, with a large number of deaths occurring in intensive care units (ICUs). This study aimed to verify the occurrence of and understand the factors related to mortality in adult patients with COVID-19 admitted to the ICU in a tertiary hospital. This is a retrospective cohort study, which included COVID-19 patients admitted between March 2020 and December 2021. A total of 588 patients were included, of whom the majority (55.27%) did not survive. Invasive mechanical ventilation was the strongest predictor of the risk of death in the ICU with OR = 97.85 (95% CI = 39.10-244.86; < 0.001), along with age and Simplified Acute Physiology Score 3 (SAPS3). The length of the ICU stay was protective. Evaluating patients on invasive mechanical ventilation in isolation, using an adjusted model, we found the following risk factors: use of vasopressin, renal replacement therapy, red cell distribution width > 15, use of hydrocortisone, and age in years. Protective factors included the days of mechanical ventilation use, being admitted from another service, and being of female sex. Identifying early predictors of mortality in patients with COVID-19 who require hospitalization is essential in the search for actions to prevent and manage complications, which can increase the survival of these patients and reduce the impact on health services.

References
1.
Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

2.
Barbalho I, Fernandes F, Barros D, Paiva J, Henriques J, Morais A . Electronic health records in Brazil: Prospects and technological challenges. Front Public Health. 2022; 10:963841. PMC: 9669479. DOI: 10.3389/fpubh.2022.963841. View

3.
Rezaei F, Ghelichi-Ghojogh M, Hemmati A, Ghaem H, Mirahmadizadeh A . Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran. J Prev Med Hyg. 2022; 62(4):E808-E813. PMC: 9104670. DOI: 10.15167/2421-4248/jpmh2021.62.4.2130. View

4.
Ozdin M, Cokluk E, Yaylaci S, Koroglu M, Genc A, Cekic D . Evaluation of coagulation parameters: Coronavirus disease 2019 (COVID-19) between survivors and nonsurvivors. Rev Assoc Med Bras (1992). 2021; 67Suppl 1(Suppl 1):74-79. DOI: 10.1590/1806-9282.67.Suppl1.20200816. View

5.
Aziz F, Reisinger A, Aberer F, Sourij C, Tripolt N, Siller-Matula J . Simplified Acute Physiology Score 3 Performance in Austrian COVID-19 Patients Admitted to Intensive Care Units with and without Diabetes. Viruses. 2022; 14(4). PMC: 9025097. DOI: 10.3390/v14040777. View